netFormulary
 Report : A-Z NHS England items in Formulary 17/09/2019 02:00:17
[Back]
 
Section Status NHS England Name
05.03.01 Formulary MHS England Abacavir Ziagen®
05.03.01 Formulary MHS England Abacavir / dolutegravir / lamivudine Triumeq®
08.01.05 Formulary MHS England Abemaciclib Verzenios®
10.01.03 Formulary MHS England Adalimumab Humira® Imraldi ®
08.01.05 Formulary MHS England Alectinib Alecensa ®
08.01.05 Restricted Use MHS England Arsenic Trioxide Trisenox®
08.01.05 Restricted Use MHS England Atezolizumab Tecentriq ®
08.01.05 Restricted Use MHS England Avelumab Bavencio®
08.02.04 Non Formulary MHS England Axicabtagene ciloleucel YESCARTA®
10.01.03 Formulary MHS England Belimumab Benlysta®
03.04.02 Formulary MHS England Benralizumab Fasenra®
08.01.05 Formulary MHS England Binimetinib Mektovi®
08.01.05 Formulary MHS England Brigatinib Alunbrig®
08.01.03 Formulary MHS England Cladribine MAVENCLAD ®
08.01.05 Formulary MHS England Daratumumab DARZALEX ®
08.02.04 Formulary MHS England Dinutuximab beta  Qarziba®
08.01.05 Restricted Use MHS England Durvalumab Imfinzi®
08.01.05 Formulary MHS England Encorafenib Braftovi®
08.01.05 Formulary MHS England GEMTUZUMAB - OZOGAMICIN  
08.02.04 Formulary MHS England Glatiramer Acetate Copaxone®
05.03.03.02 Formulary MHS England Glecaprevir and Pibrentasvir Maviret®
01.05.03 Formulary MHS England Golimumab Simponi®
08.01.05 Formulary MHS England Inotuzumab ozogamicin Besponsa®
08.01.05 Formulary MHS England Ixazomib Ninlaro®
08.01.05 Formulary MHS England Lenvatinib Kisplyx®
08.01.03 Formulary MHS England Liposomal Cytarabine–Daunorubicin  Vyxeos®
08.03.04.03 Formulary MHS England Lutetium (177Lu) oxodotreotide Lutathera®
03.04.02 Restricted Use MHS England Mepolizumab Nucala®
08.01.05 Restricted Use MHS England Midostaurin Rydapt®
08.01.05 Restricted Use MHS England Niraparib Zejula®
08.02 Formulary MHS England Ocrelizumab Ocrevus®
03.04.02 Formulary MHS England Omalizumab Xolair®
08.01.05 Restricted Use MHS England Palbociclib. IBRANCE®
03.11 Formulary MHS England Pirfenidone Capsules Esbriet®
08.01.05 Restricted Use MHS England Regorafenib Stivarga ®
08.01.05 Restricted Use MHS England Ribociclib Kisqali®
05.03.03.02 Formulary MHS England Sofosbuvir-Velpatasvir-Voxilaprevir Vosevi®
13.05.03 Formulary MHS England Tildrakizumab Ilumetri®
08.01.05 Formulary MHS England Tivozanib Fotivda ®
08.01.05 Formulary MHS England Venetoclax Venclyxto ®
08.01.05 Restricted Use MHS England Vismodegib Erivedge ®
Berkshire West NHS